Elutia Inc

ELUT | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.85

$0 (-0.40%)

Sep 22, 2026, 11:54 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.40%

(1D)

Rating

Updated: Sep 1, 2026

59.5

Fundamentals Strong

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $37.47M

1D Range

0.83 0.85

52W Range

0.50 1.39

Valuation (TTM)

PE 0.89

PB 2.40

EV/EBITDA -0.91

Valuation (NTM)

Forward PE N/A

Forward PEG -0.05

Price Target $8.88

Cash Flow

FCF Yield -120.5%

SBC Adj. FCF Yield -133.0%

SBC Impact -10.3%

Margins

Gross Margin 57.8%

Operating Margin -194.0%

FCF Margin -374.8%

Growth (CAGR)

Revenue 3Y | 5Y -27.1% | -22.0%

Dil EPS 3Y | 5Y 189.1% | 44.9%

FCF 3Y | 5Y -34.8% | -24.3%

Returns

ROA 118.7%

ROE 940.8%

ROIC -79.3%

Financial Health

Net Cash

$15.52M

Current Ratio 1.77

Interest Coverage 6.77

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women’...

Sector Healthcare

Industry Biotechnology

Employees 26

IPO Date Oct 6, 2020

Website elutia.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 12, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞